A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
推出的年份: 1989
副标题
树号: C15.604.515.880, C20.683.515.950
MeSH 单一 ID: D015275
进入的组:
Syndrome, Tumor Lysis
Syndromes, Tumor Lysis
Tumor Lysis Syndromes
Tumour Lysis Syndrome
Syndrome, Tumour Lysis
Syndromes, Tumour Lysis
Tumour Lysis Syndromes
早前的内容:
Antineoplastic Agents, Combined/adverse effects/therapeutic use (1980-1988)
留言 (0)